OncoSec Announces $15 Million At Market Investment from Alpha Holdings, Inc.

SAN DIEGO and PENNINGTON, N.J., Sept. 4, 2018 -- (Healthcare Sales & Marketing Network) -- OncoSec Medical Incorporated (OncoSec) (NASDAQ : ONCS ), a company developing intratumoral cancer immunotherapies, today announced that it has secured a $15 million... Biopharmaceuticals, Oncology, Venture Capital OncoSec Medical, intratumoral, immunotherapy, TAVO
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news